Home/Filings/4/0001429932-26-000002
4//SEC Filing

Elston George 4

Accession 0001429932-26-000002

CIK 0001314102other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:10 PM ET

Size

20.2 KB

Accession

0001429932-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Elston George
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-03+19,66776,781 total
  • Tax Payment

    Common Stock

    2026-01-03$17.48/sh6,324$110,54470,457 total
  • Exercise/Conversion

    Common Stock

    2026-01-05+15,00085,457 total
  • Tax Payment

    Common Stock

    2026-01-05$17.43/sh4,403$76,74481,054 total
  • Award

    Restricted Stock Units

    2026-01-02+63,00063,000 total
    Exercise: $0.00Common Stock (63,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2026-01-02+126,000126,000 total
    Exercise: $17.48Exp: 2036-01-02Common Stock (126,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-0319,66739,333 total
    Exercise: $0.00Common Stock (19,667 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-0515,00015,000 total
    Exercise: $0.00Common Stock (15,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    25,000
Footnotes (6)
  • [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
  • [F2]These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]The restricted stock units will vest in three ratable annual installments beginning January 2, 2027.
  • [F4]The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years.
  • [F5]The restricted stock units vest in three ratable annual installments beginning January 3, 2026.
  • [F6]The restricted stock units vest in three ratable annual installments beginning January 5, 2025.

Issuer

EyePoint, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001429932

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:10 PM ET
Size
20.2 KB